Literature DB >> 16088210

Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels.

Christopher L Kepley1.   

Abstract

BACKGROUND: The high-affinity IgE receptor, FcepsilonRI, is unresponsive on mast cells and basophils from people in several populations through an unknown mechanism. Similarly, FcepsilonRI-positive basophils from 'nonreleasers' are IgE-unresponsive and are deficient in the tyrosine kinase Syk.
OBJECTIVE: To test the hypothesis that cross-linking FcepsilonRI on mast cells and basophils leads to FcepsilonRI nonresponsiveness through reduction in Syk protein levels.
METHODS: Human mast cells and basophils were used to determine if FcepsilonRI hyporesponsiveness correlated with reduced Syk levels.
RESULTS: It is shown that suboptimal antigen challenge, that did not lead to significant mediator release, induced nonresponsiveness and correlated with reduced Syk. Other IgE-associated signaling molecules were unaffected by the same treatment. The ability of IgE-unresponsive mast cells to regain FcepsilonRI responsiveness is paralleled by increased cellular Syk levels in vitro. The reduction of Syk levels with suboptimal antigen concentrations was calcium independent and mediated through a proteasome-dependent mechanism.
CONCLUSION: These findings confirm and extend our knowledge about a novel regulatory mechanism for maintaining FcepsilonRI in a quiescent state. This mechanism may also explain why low concentrations of allergen given to patients during allergen immunotherapy induce FcepsilonRI nonresponsiveness and therapeutic benefit without inducing systemic anaphylaxis. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16088210     DOI: 10.1159/000087355

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  25 in total

Review 1.  State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve?

Authors:  Salvatore Chirumbolo
Journal:  Blood Transfus       Date:  2011-12-21       Impact factor: 3.443

2.  The safety and efficacy of sublingual and oral immunotherapy for milk allergy.

Authors:  Corinne A Keet; Pamela A Frischmeyer-Guerrerio; Ananth Thyagarajan; John T Schroeder; Robert G Hamilton; Stephen Boden; Pamela Steele; Sarah Driggers; A Wesley Burks; Robert A Wood
Journal:  J Allergy Clin Immunol       Date:  2011-11-30       Impact factor: 10.793

Review 3.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

4.  Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2.

Authors:  Judith A Woodfolk; Jill Glesner; Paul W Wright; Christopher L Kepley; Mi Li; Martin Himly; Lyndsey M Muehling; Alla Gustchina; Alexander Wlodawer; Martin D Chapman; Anna Pomés
Journal:  J Biol Chem       Date:  2015-12-07       Impact factor: 5.157

5.  In vitro desensitization of human skin mast cells.

Authors:  Wei Zhao; Gregorio Gomez; Matthew Macey; Christopher L Kepley; Lawrence B Schwartz
Journal:  J Clin Immunol       Date:  2011-10-19       Impact factor: 8.317

Review 6.  New approaches to allergen immunotherapy.

Authors:  Christopher L Kepley
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

7.  Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children.

Authors:  A Thyagarajan; S M Jones; A Calatroni; L Pons; M Kulis; C S Woo; M Kamalakannan; B P Vickery; A M Scurlock; A Wesley Burks; W G Shreffler
Journal:  Clin Exp Allergy       Date:  2012-08       Impact factor: 5.018

Review 8.  Immunotherapy in allergy and cellular tests: state of art.

Authors:  Salvatore Chirumbolo
Journal:  Hum Vaccin Immunother       Date:  2014-05-02       Impact factor: 3.452

9.  Subthreshold desensitization of human basophils re-capitulates the loss of Syk and FcεRI expression characterized by other methods of desensitization.

Authors:  D MacGlashan
Journal:  Clin Exp Allergy       Date:  2012-07       Impact factor: 5.018

10.  Syk expression in peripheral blood leukocytes, CD34+ progenitors, and CD34-derived basophils.

Authors:  Susan S Ishmael; Donald W MacGlashan
Journal:  J Leukoc Biol       Date:  2009-11-04       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.